How to order a MyChoice test

MyChoice HRD Companion Diagnostic Test is available in many countries all over the world either via local labs in your country or Myriad Genetics’ central laboratory in Salt Lake City, USA.

Please find below further information on availability in different regions and links to relevant information and forms. If you are a patient, you can speak to your doctor for more information on HRD testing.

Easy ordering, fast results

European Union, UK and countries accepting CE

MyChoice CDx Plus

MyChoice CDx Plus is a CE marked device and has been designed to conform to the applicable standards and the general safety and performance requirements of the European Directive 98/79/EC (in vitro Diagnostic Medical Devices). The declaration of conformity is issued under the responsibility of Myriad Genetic Laboratories, Inc.

The technical specifications for MyChoice CDx Plus including the intended use can be found here.

Click on the report to the right to view an example MyChoice CDx Plus result or see the full report here.

MyChoice CDx Plus is available in local partner labs

  • France
    Centre Georges-François Leclerc - Département de Biologie et de Pathologie des Tumeurs
    Dr Romain BOIDOT
    1, rue Professeur Marion
    21079 Dijon Cedex
    France
    www.CGFL.fr
    Tel direct : +33 (0) 3 80 73 77 67
    Secrétariat : +33 (0) 3 45 34 81 20
    Fax : +33 (0) 3 80 73 77 82
    E-mail : RBoidot@cgfl.fr
    Download test request form

    What to send when ordering MyChoice from Centre Georges-François Leclerc:​
    • Test request form​
    • Tumor tissue​
    • Corresponding pathology report​
    • Copy of initial prescription
  • Germany
    Institut für Pathologie – HRD Testung
    UKGM - Universitätsklinikum Marburg
    Prof. Dr. med. Carsten Denkert
    Philipps-Universität Marburg
    Baldingerstraße 1
    35043 Marburg
    Deutschland
    www.ukgm.de/ugm_2/deu/umr_pat/29737.html
    Telefon: +49 (0) 6421/58-62270
    Fax: +49 (0) 6421/58-65640
    E-mail: HRD.Diagnostik.MR@uk-gm.de
    Download test request form

    What to send when ordering MyChoice from UKGM:
    • Test request form
    • Paraffin block with tumor tissue
    • Corresponding pathology report​
    • Patient's consent form
    • Cost coverage​
      • For patients with statutory health insurance: Referral form for molecular diagnostics ("Genomic Instability NGS: HRD/BRCA/HRR")​
      • For patients with private health insurance/self-pay: Billing address and signature for cost coverage.​
    • Optional: Previous BRCA result is attached (only if BRCA has already been tested. If no result is attached, BRCA testing has not been conducted so far).

Please note that test result reports may look different when ordering from a partner lab.

Not in these countries?

If there are no labs in your country, you can send a sample to Myriad’s central laboratory in Salt Lake City, USA. Simply order a sample transportation box and follow the instructions for preparing and shipping your sample.

If you need a fillable test request form, you can find this below in different languages.

Countries outside US, UK, Japan and European Union not accepting CE

MyChoice HRD Plus

The technical specifications for MyChoice HRD Plus including the intended use can be found here.

Click on the report to the left to view an example MyChoice HRD Plus result or see the full report here.

To begin using MyChoice HRD Plus Companion Diagnostic Test to guide your ovarian cancer treatment decisions, please order a sample transportation set below.

If you need a fillable test request form, you can find this below in different languages.

United States

MyChoice CDx

The technical specifications for MyChoice CDx can be found here.

To begin using MyChoice CDx Companion Diagnostic Test to guide your ovarian cancer treatment decisions please visit our US page.

Information for pathologists & surgeons

Selecting a sample

High-quality sample selection means high-quality patient care.

We understand sample selection cannot always be optimal, but MyChoice can give the results each woman needs with enough tumor content. Ensuring specimens have at least 30% tumor cells in tissue or fluid samples is one of the best ways to ensure MyChoice test success.

Preferably, the tumor specimen should also be treatment-naïve.

For more tips like this and guidance on how to select and prepare a sample for HRD testing, please download our pathologist guide.